Bollard Group’s Elevance Health ELV Stock Holding History

Bollard Group’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-25	Closed	-$11K	–	470
2023 Q2	$11K	Buy	+25	New	+$11.5K	﹤0.01%	290

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Bollard Group's ELV Position: Q3 2023 in Review

Bollard Group sold out of Elevance Health (ELV) in Q3 2023, closing a stake of 25 shares — an estimated $11K sold.

Bollard Group first reported a position in ELV in Q2 2023 and held it in 1 quarter. The position peaked at $11K in Q2 2023. 1,523 funds tracked by Wall St. Rank hold ELV as of Q3 2023.

Bollard Group reported no remaining Elevance Health position as of Q3 2023 after selling out during the quarter.
Bollard Group sold 25 Elevance Health shares in Q3 2023, an estimated $11K.
Bollard Group first reported a position in Elevance Health in Q2 2023 and held it in 1 quarter.
Bollard Group's Elevance Health position peaked at $11K in Q2 2023.
1,523 funds tracked by Wall St. Rank held Elevance Health as of Q3 2023.

Based on Bollard Group's 13F filing for Q3 2023, filed 14 Nov 2023.